• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的免疫逃逸机制。

Mechanism of immune evasion in breast cancer.

作者信息

Wang Mozhi, Zhang Changwang, Song Yongxi, Wang Zhenning, Wang Yaojia, Luo Fang, Xu Yujie, Zhao Yi, Wu Zhonghua, Xu Yingying

机构信息

Department of Breast Surgery.

Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.

出版信息

Onco Targets Ther. 2017 Mar 14;10:1561-1573. doi: 10.2147/OTT.S126424. eCollection 2017.

DOI:10.2147/OTT.S126424
PMID:28352189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5359138/
Abstract

Breast cancer (BC) is the most common malignant tumor among women, with high morbidity and mortality. Its onset, development, metastasis, and prognosis vary among individuals due to the interactions between tumors and host immunity. Many diverse mechanisms have been associated with BC, with immune evasion being the most widely studied to date. Tumor cells can escape from the body's immune response, which targets abnormal components and foreign bodies, using different approaches including modification of surface antigens and modulation of the surrounding environment. In this review, we summarize the mechanisms and factors that impact the immunoediting process and analyze their functions in detail.

摘要

乳腺癌(BC)是女性中最常见的恶性肿瘤,发病率和死亡率都很高。由于肿瘤与宿主免疫之间的相互作用,其发病、发展、转移和预后存在个体差异。许多不同的机制都与乳腺癌有关,其中免疫逃逸是迄今为止研究最广泛的。肿瘤细胞可以通过不同的方式逃避机体针对异常成分和异物的免疫反应,包括修饰表面抗原和调节周围环境。在这篇综述中,我们总结了影响免疫编辑过程的机制和因素,并详细分析了它们的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/5359138/06ddcb77de8c/ott-10-1561Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/5359138/ef135798b3db/ott-10-1561Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/5359138/06ddcb77de8c/ott-10-1561Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/5359138/ef135798b3db/ott-10-1561Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/5359138/06ddcb77de8c/ott-10-1561Fig2.jpg

相似文献

1
Mechanism of immune evasion in breast cancer.乳腺癌的免疫逃逸机制。
Onco Targets Ther. 2017 Mar 14;10:1561-1573. doi: 10.2147/OTT.S126424. eCollection 2017.
2
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy.乳腺癌中的细胞免疫反应与免疫逃逸机制:免疫治疗的决定因素
Breast Care (Basel). 2016 Apr;11(2):102-7. doi: 10.1159/000446061. Epub 2016 Apr 27.
3
Role of PD-1 in Immunity and Diseases.PD-1 在免疫和疾病中的作用。
Curr Top Microbiol Immunol. 2017;410:75-97. doi: 10.1007/82_2017_67.
4
Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion.肿瘤内在PD-L1信号在癌症起始、发展和治疗中的作用:超越免疫逃逸
Front Oncol. 2018 Sep 19;8:386. doi: 10.3389/fonc.2018.00386. eCollection 2018.
5
Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.EMT 与 PD-L1 信号转导之间的通讯:肿瘤免疫逃逸的新见解。
Cancer Lett. 2020 Jan 1;468:72-81. doi: 10.1016/j.canlet.2019.10.013. Epub 2019 Oct 9.
6
Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.卡波氏肉瘤相关疱疹病毒增加人单核细胞中 PD-L1 和促炎细胞因子的表达。
mBio. 2017 Oct 10;8(5):e00917-17. doi: 10.1128/mBio.00917-17.
7
The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.免疫逃逸和免疫细胞浸润在乳腺癌中的作用
Breast Care (Basel). 2018 Mar;13(1):16-21. doi: 10.1159/000486585. Epub 2018 Feb 2.
8
The mechanisms on evasion of anti-tumor immune responses in gastric cancer.胃癌中抗肿瘤免疫反应逃逸的机制。
Front Oncol. 2022 Nov 10;12:943806. doi: 10.3389/fonc.2022.943806. eCollection 2022.
9
Immune response and evasion mechanisms in lip carcinogenesis: An immunohistochemical study.在唇癌发生中的免疫反应和逃逸机制:免疫组织化学研究。
Arch Oral Biol. 2019 Feb;98:99-107. doi: 10.1016/j.archoralbio.2018.09.017. Epub 2018 Sep 29.
10
[Regulatory Mechanisms of PD-L1 Expression and Its Role in Immune Evasion].[程序性死亡受体配体1(PD-L1)表达的调控机制及其在免疫逃逸中的作用]
Gan To Kagaku Ryoho. 2017 Nov;44(11):967-971.

引用本文的文献

1
XGB-BIF: An XGBoost-Driven Biomarker Identification Framework for Detecting Cancer Using Human Genomic Data.XGB-BIF:一种用于利用人类基因组数据检测癌症的基于XGBoost的生物标志物识别框架。
Int J Mol Sci. 2025 Jun 11;26(12):5590. doi: 10.3390/ijms26125590.
2
The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential.长链非编码RNA在调节三阴性乳腺癌免疫微环境中的作用:机制见解与治疗潜力
Biomolecules. 2025 Mar 20;15(3):454. doi: 10.3390/biom15030454.
3
The clinicopathological significance of BRI3BP in women with invasive breast cancer.

本文引用的文献

1
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with amplification.基因组学与组织学的整合修正了诊断,并使对具有扩增的不明原发灶难治性癌症能够进行有效治疗。
Cold Spring Harb Mol Case Stud. 2016 Nov;2(6):a001180. doi: 10.1101/mcs.a001180.
2
Immune Blockade Inhibition in Breast Cancer.乳腺癌中的免疫阻断抑制
Anticancer Res. 2016 Nov;36(11):5607-5622. doi: 10.21873/anticanres.11145.
3
CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity.
BRI3BP在浸润性乳腺癌女性中的临床病理意义。
Transl Cancer Res. 2024 Dec 31;13(12):6837-6849. doi: 10.21037/tcr-24-1113. Epub 2024 Dec 27.
4
Coordinated inflammation and immune response transcriptional regulation in breast cancer molecular subtypes.乳腺癌分子亚型中协调的炎症和免疫反应转录调控。
Front Immunol. 2024 Jun 25;15:1357726. doi: 10.3389/fimmu.2024.1357726. eCollection 2024.
5
A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era.基于纳米机器人的纳米技术时代乳腺癌治疗方法。
Int J Mol Sci. 2024 May 2;25(9):4981. doi: 10.3390/ijms25094981.
6
wMKL: multi-omics data integration enables novel cancer subtype identification via weight-boosted multi-kernel learning.wMKL:多组学数据集成通过加权多内核学习实现新型癌症亚型识别。
Br J Cancer. 2024 Apr;130(6):1001-1012. doi: 10.1038/s41416-024-02587-w. Epub 2024 Jan 26.
7
Does Laterality in Breast Cancer still have the Importance to be Studied? A Meta-analysis of Patients with Breast Cancer.乳腺癌的侧别研究是否仍具有重要意义?一项乳腺癌患者的荟萃分析。
Curr Med Chem. 2024;31(22):3360-3379. doi: 10.2174/0109298673241301231023060322.
8
Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers.揭示乳腺癌免疫微环境的作用:窥探充满希望的前沿领域。
Int J Mol Sci. 2023 Oct 18;24(20):15332. doi: 10.3390/ijms242015332.
9
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.基于机器学习的乳腺癌肿瘤浸润淋巴细胞评估中的陷阱:国际肿瘤免疫生物标志物工作组关于乳腺癌的报告。
J Pathol. 2023 Aug;260(5):498-513. doi: 10.1002/path.6155. Epub 2023 Aug 23.
10
miR155 deficiency reduces breast tumor burden in the MMTV-PyMT mouse model.miR155 缺失可减少 MMTV-PyMT 小鼠模型中的乳腺肿瘤负担。
Physiol Genomics. 2022 Nov 1;54(11):433-442. doi: 10.1152/physiolgenomics.00057.2022. Epub 2022 Sep 19.
CCR2 影响调节性 T 细胞向肿瘤的迁移,并作为环磷酰胺敏感性的生物标志物。
Cancer Res. 2016 Nov 15;76(22):6483-6494. doi: 10.1158/0008-5472.CAN-16-0984. Epub 2016 Sep 28.
4
Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy.联合免疫检查点抑制剂和激酶抑制超分子疗法以增强抗癌疗效。
ACS Nano. 2016 Oct 25;10(10):9227-9242. doi: 10.1021/acsnano.6b01600. Epub 2016 Sep 29.
5
Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer.乳腺癌中免疫调节配体B7家族的综合分子谱分析。
Oncoimmunology. 2016 Jul 11;5(8):e1207841. doi: 10.1080/2162402X.2016.1207841. eCollection 2016 Aug.
6
Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond.调节乳腺癌免疫系统的策略:检查点抑制剂及其他。
Ther Adv Med Oncol. 2016 Sep;8(5):360-74. doi: 10.1177/1758834016658423. Epub 2016 Jul 10.
7
Fatal attraction: TICs and MDSCs.致命吸引力:肿瘤浸润性细胞(TICs)与骨髓来源的抑制性细胞(MDSCs)
Cell Cycle. 2016 Oct;15(19):2545-2546. doi: 10.1080/15384101.2016.1204854. Epub 2016 Aug 30.
8
A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.A 型整合素金属蛋白酶(ADAM)17 酶解干扰素-γ。
Sci Rep. 2016 Aug 30;6:32259. doi: 10.1038/srep32259.
9
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.糖基化和程序性死亡配体 1 的稳定抑制 T 细胞活性。
Nat Commun. 2016 Aug 30;7:12632. doi: 10.1038/ncomms12632.
10
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling.早期乳腺癌女性患者术前单剂量伊匹木单抗和/或冷冻消融联合全面免疫分析的初步研究。
Clin Cancer Res. 2016 Dec 1;22(23):5729-5737. doi: 10.1158/1078-0432.CCR-16-0190. Epub 2016 Aug 26.